Back to Atlas
BSemi-durableStandard research/education caution
CMP-0216
Experimental
MEPB
Neuromuscular / Neuroprotective
Potential neuromuscular protection in spinal and bulbar muscular atrophy models
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Small molecule
- Primary mechanism
- Androgen receptor toxicity modulation in SBMA models
- Primary market use
- Neuromuscular disease
Pharmacology
- Molecular weight (Da)
- ~402
- Oral bioavailability
- Unknown
- Half-life
- ~2–12 h small-molecule class estimate
- Route tags
- Route-dependent / verify
- Evidence level
- Preclinical
- Clinical status
- Experimental
- Value-for-money score
- 4 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Full chemical name: 1-[2-(4-methylphenoxy)ethyl]-2-[(2-phenoxyethyl)sulfanyl]-1H-benzimidazole